Location History:
- Kowloon, CN (2014 - 2015)
- Hong Kong, CN (2014 - 2017)
Company Filing History:
4 out of 607 
2 out of 4 Years Active: 2014-2017
Title: The Innovator Fanny Chui-Fun Ip: Pioneering CDK5 Inhibitor Research in Hong Kong
Introduction
Fanny Chui-Fun Ip, an esteemed inventor based in Hong Kong, China, has made significant contributions to the field of medicinal chemistry and neuropharmacology. With a total of six patents to his name, his innovative work focuses on the development of therapeutic uses of cyclin-dependent protein kinase 5 (CDK5) inhibitors, along with neuro-protective compounds that hold promise for the treatment of various diseases.
Latest Patents
Two of Fanny Chui-Fun Ip's latest patents showcase his groundbreaking research. The first patent addresses CDK5 inhibitors and their therapeutic applications. These natural inhibitors, derived from specific roots, exhibit unique structural properties that differentiate them from existing CDK inhibitors. Notably, they demonstrate selectivity among different cyclin-dependent kinases and show promise in inhibiting CDK5 through a mixed-type mechanism. This selectivity could potentially minimize toxicity and side effects, making them advantageous for treating conditions linked to dysfunctional CDK5 activities, including chronic pain, neuropathic pain, diabetes, cancer, and neurodegenerative disorders.
The second patent centers on neuro-protective compounds that have been isolated from refined fractions. This invention not only details the extraction process but also outlines the various applications of these compounds. Their efficacy in inhibiting NMDA receptor activity or amyloid-beta peptide is particularly noteworthy, as they may aid in improving memory and treating neurodegenerative diseases, neuropathological conditions, or epilepsy.
Career Highlights
Fanny Chui-Fun Ip has held significant roles in renowned institutions, including the Hong Kong University of Science and Technology and Biotechnology Research Corporation Limited. His research endeavors in these organizations have facilitated advancements in therapeutic approaches, further solidifying his status as a leading inventor in the biotechnology sector.
Collaborations
Throughout his career, Fanny Chui-Fun Ip has collaborated with esteemed colleagues, including Nancy Yuk-Yu Ip and Yueqing Hu. These partnerships have fostered a collaborative research environment, leading to innovative breakthroughs in the study of CDK inhibitors and neuro-protective compounds.
Conclusion
Fanny Chui-Fun Ip's thrilling journey as an inventor not only highlights his dedication to advancing science but also underscores the importance of innovative research in addressing critical health challenges. His work continues to pave the way for new therapeutic avenues, impacting the future landscape of medicine and highlighting the invaluable role of inventors in the process of innovation.